Advanced Medical Isotopes Corporation Reports Progress Towards Seeking FDA Clearance For The Y-90 Radiogel Device

KENNEWICK, Wash.--(BUSINESS WIRE)--Advanced Medical Isotope Corporation ("AMIC") (OTC: ADMD), a late stage development company engaged in the development of brachytherapy devices for therapeutic applications, today announced its progress in seeking FDA clearance for marketing of its lead product, the Y-90 RadioGelâ„¢ device.

CEO Jim Katzaroff and the lead scientific and medical advisory team from AMIC met at the FDA offices last week to discuss next steps, expectations and required testing to progress towards obtaining marketing clearance for the Y-90 RadioGelâ„¢ device. The FDA and AMIC team are working closely in order to obtain all appropriate data and benchmarks the FDA requires in order to proceed with providing final clearance for marketing the device in the United States. AMIC intends to seek classification and clearance as a class II medical device through a de novo application.

Help employers find you! Check out all the jobs and post your resume.

Back to news